PubMed Health⌕ Search

Biomedical subjects

Yoshio Arakawa

Publications and source records attributed to Yoshio Arakawa.

1 recordsLinked to original sources

Reverse hydroxamate-based selective TACE inhibitors.

Reverse hydroxamate-based selective TACE inhibitors are described. They have potent TACE inhibitory activities and excellent selectivities against MMP-1, 2, 3, 8, 9, 13, 14, and 17. One representative compound, 18 has demonstrated an excellent oral inhibitory activity of the lipopolysaccharide (LPS)-stimulated TNF-alpha production in rats.

ADAM Proteins↗